Artal Group’s Dynavax Technologies DVAX Stock Holding History

Artal Group’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-200,000	Closed	-$3.45M	–	121
2017 Q4	$3.74M	Buy	200,000 +50,000	+33%	+$1M	0.06%	78
2017 Q3	$3.23M	Buy	+150,000	New	+$2.37M	0.06%	80

Other funds holding DVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Artal Group's DVAX Position: Q1 2018 in Review

Artal Group sold out of Dynavax Technologies (DVAX) in Q1 2018, closing a stake of 200,000 shares — an estimated $3.45M sold.

Artal Group first reported a position in DVAX in Q3 2017 and held it in 2 quarters. The position peaked at $3.74M in Q4 2017. 139 funds tracked by Wall St. Rank hold DVAX as of Q1 2018.

Artal Group reported no remaining Dynavax Technologies position as of Q1 2018 after selling out during the quarter.
Artal Group sold 200,000 Dynavax Technologies shares in Q1 2018, an estimated $3.45M.
Artal Group first reported a position in Dynavax Technologies in Q3 2017 and held it in 2 quarters.
Artal Group's Dynavax Technologies position peaked at $3.74M in Q4 2017.
139 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2018.

Based on Artal Group's 13F filing for Q1 2018, filed 10 May 2018.